Cytologic screening and human papilloma virus test in women undergoing artificial fertilization

Acta Obstetricia et Gynecologica Scandinavica

Volumn 81, Issue 10, 2002, Pages 949-953

  Lundqvist, Monalill ^a   Westin, Cecilia ^a   Lundkvist, ÖRjan ^a   Simberg, Niklas ^a   Strand, Anders ^b   Andersson, Sonja ^c   Wilander, Erik ^c  

^a Section of Obstetrics and Gynecology   (Sweden)

^b Section of Dermatology and Venereology   (Sweden)

^c UPPSALA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Cytology; Female; Human papilloma virus; In vitro fertilization; Infertility; Pregnancy

Indexed keywords

ADULT; ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; CYTODIAGNOSIS; DISEASE ASSOCIATION; FEMALE; FEMALE INFERTILITY; FERTILIZATION IN VITRO; HUMAN; HUMAN TISSUE; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MEDICAL RECORD; POLYMERASE CHAIN REACTION; PREVALENCE; PRIORITY JOURNAL; SENSITIVITY ANALYSIS; SOCIAL SECURITY; UTERINE CERVIX CYTOLOGY; VIRUS EXAMINATION; VIRUS INFECTION; WART VIRUS;

ADULT; CARCINOMA, SQUAMOUS CELL; CERVICAL INTRAEPITHELIAL NEOPLASIA; DNA PROBES, HPV; FEMALE; FERTILIZATION IN VITRO; HUMANS; INFERTILITY; MIDDLE AGED; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; PREVALENCE; SEX FACTORS; TUMOR VIRUS INFECTIONS; UTERINE CERVICAL NEOPLASMS; VAGINAL SMEARS;

EID: 0036799155     PISSN: 00016349     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1600-0412.2002.811009.x     Document Type: Article

References (24)

1. Zur Hausen H. Viruses in human cancers. Science 1991; 254: 1167-73.
2. Gross GE, Barasso R, eds. Human Papilloma Virus A Clinical Atlas. Berlin/Wiesbaden: Ullstein Mosby GmbH & Co KG, 1997.
3. Walboomers JM, Jacobs MV, Manos MM, Bosch FX, Kummer JA, Shah KV et al. Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol 1999; 189: 12-9.
4. Gustafsson L, Adami H-O. Natural history of cervical neoplasia: consistent results obtained by an identification technique. Br J Cancer 1989; 60: 132-41.
5. Östör AG. Natural history of cervical intraepithelial neoplasia: a critical review. Int J Gynecol Pathol 1993; 12: 186-92.
6. Nevin J, Soeters R, Dehaeck K, Bloch B, van-Wyk L. Cervical carcinoma associated with pregnancy. Obstet Gynecol Surv 1995; 50: 228-39.
7. Lundqvist M, Rova K, Simberg N, Lundkvist Ö. Embryo transfer after two or five days of IVF culture - a retrospective comparison. Acta Obstet Gynacol Scand, in press.
8. Lungu O, Wright TC, Silverstein S. Typing of human papillomavirus by polymerase chain reaction amplification with L1 consensus primer RFLP analysis. Mol Cell Probes 1992; 6: 145-52.
9. Saiki RK, Chang CA, Levenson CH, Warren TC, Boehm CD, Kazaian HH et al. Diagnosis of sickle cell anemia and β-thalassemia with enzymatically amplified DNA and nonradioactive allele-specific oligonucleotide probes. N Engl J Med 1988; 319: 537-41.
10. De Roda Husman A-M, Walboomers JMM, van den Brule AJC, Meijer CJLM, Snijders PJF. The use of the general primers GP5 and GP6 elongated at their 3′ ends with adjacent highly conserved sequences improves human papillomavirus detection by PCR. J General Virol 1995; 76: 1057-62.
11. Zehbe I, Wilander E. Two consensus primer systems and nested polymerase chain reaction for human papillomavirus detection in cervical biopsies. Hum Pathol 1996; 27: 812-5.
12. Zehbe I, Evander M, Edlund K, Rylander E, Wadell G, Wilander E. Non-isotopic detection and typing of human papillomavirus (HPV) by use of polymerase chain reaction and single strand conformation polymorphism (PCR-SSCP). Am J Surg Pathol, part B. Diagn Mol Pathol 1996; 5: 206-13.
13. Alemi M, Andersson S, Sällström J, Wilander E. Rapid test for identification of human papillomavirus 16, E6 L83V variant. Diagn Mol Pathol 1999; 8: 97-100.
14. Bavin PJ, Giles JA, Deery A, Crow J, Griffiths PD, Emery VC et al. Use of semi-quantitative PCR for human papillomavirus DNA type 16 to identify women with high grade cervical disease in a population presenting with mildly dyskaryotic smear report. Br J Cancer 1992; 67: 602-5.
15. Cuzick J, Szarewski A, Terry G, Ho L, Hanby A, Maddox P et al. Human papillomavirus testing in primary cervical screening. Lancet 1995; 345: 1533-6.
16. Cox JT, Lorincz AT, Schiffman MH. HPV testing by hybrid capture appears to be useful in triaging women with cytological diagnosis of ASCUS. Am J Obstet Gynecol 1995; 172: 946-54.
17. Fredriksson A, Larsson B, persson E, Auer G, Johansson B, Kalantari M et al. HPV-types, cytological and histopathological findings in three groups of women with possible HPV-related disease. Acta Obstet Gynecol Scand 1996; 75: 556-62.
18. Persson G, Andersson K, Krantz I. Symptomatic genital papillomavirus infection in a community. Acta Obstet Gynecol Scand 1996; 75: 287-90.
19. Zehbe I, Strand A, Chua K-L, Wilander E. Cytological evaluation and molecular human papillomavirus test of cervical scrapings from women treated for condyloma. Gynaecol Obstet Invest 1996; 42: 128-32.
20. Walboomers JMM. Human papillomavirus detection and cervical cancer screening. Patologia 1999; 32: 270.
21. Sigurdsson K. Cervical cancer, Pap smear and HPV testing: an update of the role of organized Pap smear screening and HPV testing. Acta Obstet Gynecol Scand 1999; 78: 467-77.
22. Parkendorf UW, Bornman MS, Du Plessis DJ. Prevalence of human papillomavirus in men attending the infertility clinic. Andrologia 1998; 30: 11-4.
23. Rohde V, Erles K, Sattler HP, Derouet H, Wullich B, Schlehofer JR. Detection of adeno-associated virus in human semen: does viral infection play a role in the pathogenesis of male infertility? Fertil Steril 1999; 72: 814-6.
24. Zehbe I, Wilander E, Delius H, Tommasino M. Variants of the HPV 16, E6 oncoprotein are more predictive for progression to invasive cervical disease than the prototype. Cancer Res 1998; 58: 829-33.